• レポートコード:MRC2-11QY12103 • 出版社/出版日:QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、91ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:ヘルスケア |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は頭頸部がん診断のグローバル市場について調査・分析したレポートです。種類別(画像診断、内視鏡検査、生検検査、血液検査、歯科診断、その他)市場規模、用途別(病院、専門クリニック、外来手術センター)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別頭頸部がん診断の競争状況、市場シェア ・世界の頭頸部がん診断市場:種類別市場規模 2015年-2020年(画像診断、内視鏡検査、生検検査、血液検査、歯科診断、その他) ・世界の頭頸部がん診断市場:種類別市場規模予測 2021年-2026年(画像診断、内視鏡検査、生検検査、血液検査、歯科診断、その他) ・世界の頭頸部がん診断市場:用途別市場規模 2015年-2020年(病院、専門クリニック、外来手術センター) ・世界の頭頸部がん診断市場:用途別市場規模予測 2021年-2026年(病院、専門クリニック、外来手術センター) ・北米の頭頸部がん診断市場分析:米国、カナダ ・ヨーロッパの頭頸部がん診断市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの頭頸部がん診断市場分析:日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の頭頸部がん診断市場分析:メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの頭頸部がん診断市場分析:トルコ、サウジアラビア、UAE等 ・企業情報(企業概要、製品概要、販売量、企業動向) - 掲載企業(変更可能性あり):GE Healthcare、Philips Healthcare、Siemens Healthcare、Varian Medical Systems ・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Head and neck cancer begins in squamous cells that line the mucosal surfaces of the head and neck such as, inside the mouth, the nose, and the throat. The head and neck cancers include specific areas of the body such as oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and salivary glands. Alcohol and tobacco are the two most common risk factors for head and neck cancers. Other risk factors for head and neck cancers include consumption of preserved or salted foods, occupational exposure to wood dust, Epstein-Barr virus infection, and poor oral hygiene.
The market for head and neck cancer diagnostics is expected to increase year on year with an increasing incidence of the disease. Though this form of cancer is not prevalent in all its forms in the US, it has increased presence and incidence in countries of Asia, Africa and to some extent Europe, making its screening and early detection of high importance to affect proper treatment and care. Proper detection at an early stage can lead to proper treatment and long healthier life. Rise in the aging population that increased the prevalence of chronic diseases, especially head and neck related cancers, increasing awareness towards cancer, and rise in the healthcare expenditure of people and government. However, Low Adoption Rate of Digital Technology Based Systems, Conventional CT and MRI Scanners, Excise Duty Imposed on Sale of Medical Devices in Mature Markets
Market Analysis and Insights: Global Head and Neck Cancer Diagnostics Market
The global Head and Neck Cancer Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Head and Neck Cancer Diagnostics Scope and Market Size
Head and Neck Cancer Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Head and Neck Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
GE Healthcare
Philips Healthcare
Siemens Healthcare
Varian Medical Systems
…
Market segment by Type, the product can be split into
Diagnostic Imaging
Endoscopy Screening
Bioscopy Screening
Blood Tests
Dental Diagnostic
Others
Market segment by Application, split into
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Head and Neck Cancer Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Head and Neck Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnostic Imaging
1.4.3 Endoscopy Screening
1.4.4 Bioscopy Screening
1.4.5 Blood Tests
1.4.6 Dental Diagnostic
1.4.7 Others
1.5 Market by Application
1.5.1 Global Head and Neck Cancer Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Head and Neck Cancer Diagnostics Market Perspective (2015-2026)
2.2 Global Head and Neck Cancer Diagnostics Growth Trends by Regions
2.2.1 Head and Neck Cancer Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Head and Neck Cancer Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Head and Neck Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Head and Neck Cancer Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Head and Neck Cancer Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Head and Neck Cancer Diagnostics Players by Market Size
3.1.1 Global Top Head and Neck Cancer Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Head and Neck Cancer Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Head and Neck Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Head and Neck Cancer Diagnostics Market Concentration Ratio
3.2.1 Global Head and Neck Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Head and Neck Cancer Diagnostics Revenue in 2019
3.3 Head and Neck Cancer Diagnostics Key Players Head office and Area Served
3.4 Key Players Head and Neck Cancer Diagnostics Product Solution and Service
3.5 Date of Enter into Head and Neck Cancer Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Head and Neck Cancer Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Head and Neck Cancer Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Head and Neck Cancer Diagnostics Market Size by Application (2015-2020)
5.2 Global Head and Neck Cancer Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Head and Neck Cancer Diagnostics Market Size (2015-2020)
6.2 Head and Neck Cancer Diagnostics Key Players in North America (2019-2020)
6.3 North America Head and Neck Cancer Diagnostics Market Size by Type (2015-2020)
6.4 North America Head and Neck Cancer Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Head and Neck Cancer Diagnostics Market Size (2015-2020)
7.2 Head and Neck Cancer Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Head and Neck Cancer Diagnostics Market Size by Type (2015-2020)
7.4 Europe Head and Neck Cancer Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Head and Neck Cancer Diagnostics Market Size (2015-2020)
8.2 Head and Neck Cancer Diagnostics Key Players in China (2019-2020)
8.3 China Head and Neck Cancer Diagnostics Market Size by Type (2015-2020)
8.4 China Head and Neck Cancer Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Head and Neck Cancer Diagnostics Market Size (2015-2020)
9.2 Head and Neck Cancer Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Head and Neck Cancer Diagnostics Market Size by Type (2015-2020)
9.4 Japan Head and Neck Cancer Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Head and Neck Cancer Diagnostics Market Size (2015-2020)
10.2 Head and Neck Cancer Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Head and Neck Cancer Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Head and Neck Cancer Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Head and Neck Cancer Diagnostics Market Size (2015-2020)
11.2 Head and Neck Cancer Diagnostics Key Players in India (2019-2020)
11.3 India Head and Neck Cancer Diagnostics Market Size by Type (2015-2020)
11.4 India Head and Neck Cancer Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Head and Neck Cancer Diagnostics Market Size (2015-2020)
12.2 Head and Neck Cancer Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Head and Neck Cancer Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Head and Neck Cancer Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GE Healthcare
13.1.1 GE Healthcare Company Details
13.1.2 GE Healthcare Business Overview
13.1.3 GE Healthcare Head and Neck Cancer Diagnostics Introduction
13.1.4 GE Healthcare Revenue in Head and Neck Cancer Diagnostics Business (2015-2020))
13.1.5 GE Healthcare Recent Development
13.2 Philips Healthcare
13.2.1 Philips Healthcare Company Details
13.2.2 Philips Healthcare Business Overview
13.2.3 Philips Healthcare Head and Neck Cancer Diagnostics Introduction
13.2.4 Philips Healthcare Revenue in Head and Neck Cancer Diagnostics Business (2015-2020)
13.2.5 Philips Healthcare Recent Development
13.3 Siemens Healthcare
13.3.1 Siemens Healthcare Company Details
13.3.2 Siemens Healthcare Business Overview
13.3.3 Siemens Healthcare Head and Neck Cancer Diagnostics Introduction
13.3.4 Siemens Healthcare Revenue in Head and Neck Cancer Diagnostics Business (2015-2020)
13.3.5 Siemens Healthcare Recent Development
13.4 Varian Medical Systems
13.4.1 Varian Medical Systems Company Details
13.4.2 Varian Medical Systems Business Overview
13.4.3 Varian Medical Systems Head and Neck Cancer Diagnostics Introduction
13.4.4 Varian Medical Systems Revenue in Head and Neck Cancer Diagnostics Business (2015-2020)
13.4.5 Varian Medical Systems Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Head and Neck Cancer Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Head and Neck Cancer Diagnostics Revenue
Table 3. Ranking of Global Top Head and Neck Cancer Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Head and Neck Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnostic Imaging
Table 6. Key Players of Endoscopy Screening
Table 7. Key Players of Bioscopy Screening
Table 8. Key Players of Blood Tests
Table 9. Key Players of Dental Diagnostic
Table 10. Key Players of Others
Table 11. Global Head and Neck Cancer Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Head and Neck Cancer Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Head and Neck Cancer Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Head and Neck Cancer Diagnostics Market Share by Regions (2015-2020)
Table 15. Global Head and Neck Cancer Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Head and Neck Cancer Diagnostics Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Head and Neck Cancer Diagnostics Market Growth Strategy
Table 21. Main Points Interviewed from Key Head and Neck Cancer Diagnostics Players
Table 22. Global Head and Neck Cancer Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 23. Global Head and Neck Cancer Diagnostics Market Share by Players (2015-2020)
Table 24. Global Top Head and Neck Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Head and Neck Cancer Diagnostics as of 2019)
Table 25. Global Head and Neck Cancer Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Head and Neck Cancer Diagnostics Product Solution and Service
Table 28. Date of Enter into Head and Neck Cancer Diagnostics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Head and Neck Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 31. Global Head and Neck Cancer Diagnostics Market Size Share by Type (2015-2020)
Table 32. Global Head and Neck Cancer Diagnostics Revenue Market Share by Type (2021-2026)
Table 33. Global Head and Neck Cancer Diagnostics Market Size Share by Application (2015-2020)
Table 34. Global Head and Neck Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 35. Global Head and Neck Cancer Diagnostics Market Size Share by Application (2021-2026)
Table 36. North America Key Players Head and Neck Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Head and Neck Cancer Diagnostics Market Share (2019-2020)
Table 38. North America Head and Neck Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 39. North America Head and Neck Cancer Diagnostics Market Share by Type (2015-2020)
Table 40. North America Head and Neck Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 41. North America Head and Neck Cancer Diagnostics Market Share by Application (2015-2020)
Table 42. Europe Key Players Head and Neck Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Head and Neck Cancer Diagnostics Market Share (2019-2020)
Table 44. Europe Head and Neck Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Head and Neck Cancer Diagnostics Market Share by Type (2015-2020)
Table 46. Europe Head and Neck Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Head and Neck Cancer Diagnostics Market Share by Application (2015-2020)
Table 48. China Key Players Head and Neck Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 49. China Key Players Head and Neck Cancer Diagnostics Market Share (2019-2020)
Table 50. China Head and Neck Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 51. China Head and Neck Cancer Diagnostics Market Share by Type (2015-2020)
Table 52. China Head and Neck Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 53. China Head and Neck Cancer Diagnostics Market Share by Application (2015-2020)
Table 54. Japan Key Players Head and Neck Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Head and Neck Cancer Diagnostics Market Share (2019-2020)
Table 56. Japan Head and Neck Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Head and Neck Cancer Diagnostics Market Share by Type (2015-2020)
Table 58. Japan Head and Neck Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Head and Neck Cancer Diagnostics Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Head and Neck Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Head and Neck Cancer Diagnostics Market Share (2019-2020)
Table 62. Southeast Asia Head and Neck Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Head and Neck Cancer Diagnostics Market Share by Type (2015-2020)
Table 64. Southeast Asia Head and Neck Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Head and Neck Cancer Diagnostics Market Share by Application (2015-2020)
Table 66. India Key Players Head and Neck Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 67. India Key Players Head and Neck Cancer Diagnostics Market Share (2019-2020)
Table 68. India Head and Neck Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 69. India Head and Neck Cancer Diagnostics Market Share by Type (2015-2020)
Table 70. India Head and Neck Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 71. India Head and Neck Cancer Diagnostics Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Head and Neck Cancer Diagnostics Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Head and Neck Cancer Diagnostics Market Share (2019-2020)
Table 74. Central & South America Head and Neck Cancer Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Head and Neck Cancer Diagnostics Market Share by Type (2015-2020)
Table 76. Central & South America Head and Neck Cancer Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Head and Neck Cancer Diagnostics Market Share by Application (2015-2020)
Table 78. GE Healthcare Company Details
Table 79. GE Healthcare Business Overview
Table 80. GE Healthcare Product
Table 81. GE Healthcare Revenue in Head and Neck Cancer Diagnostics Business (2015-2020) (Million US$)
Table 82. GE Healthcare Recent Development
Table 83. Philips Healthcare Company Details
Table 84. Philips Healthcare Business Overview
Table 85. Philips Healthcare Product
Table 86. Philips Healthcare Revenue in Head and Neck Cancer Diagnostics Business (2015-2020) (Million US$)
Table 87. Philips Healthcare Recent Development
Table 88. Siemens Healthcare Company Details
Table 89. Siemens Healthcare Business Overview
Table 90. Siemens Healthcare Product
Table 91. Siemens Healthcare Revenue in Head and Neck Cancer Diagnostics Business (2015-2020) (Million US$)
Table 92. Siemens Healthcare Recent Development
Table 93. Varian Medical Systems Company Details
Table 94. Varian Medical Systems Business Overview
Table 95. Varian Medical Systems Product
Table 96. Varian Medical Systems Revenue in Head and Neck Cancer Diagnostics Business (2015-2020) (Million US$)
Table 97. Varian Medical Systems Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Head and Neck Cancer Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Diagnostic Imaging Features
Figure 3. Endoscopy Screening Features
Figure 4. Bioscopy Screening Features
Figure 5. Blood Tests Features
Figure 6. Dental Diagnostic Features
Figure 7. Others Features
Figure 8. Global Head and Neck Cancer Diagnostics Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Head and Neck Cancer Diagnostics Report Years Considered
Figure 13. Global Head and Neck Cancer Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Head and Neck Cancer Diagnostics Market Share by Regions: 2020 VS 2026
Figure 15. Global Head and Neck Cancer Diagnostics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Head and Neck Cancer Diagnostics Market Share by Players in 2019
Figure 18. Global Top Head and Neck Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Head and Neck Cancer Diagnostics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Head and Neck Cancer Diagnostics Revenue in 2019
Figure 20. North America Head and Neck Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Head and Neck Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Head and Neck Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Head and Neck Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Head and Neck Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Head and Neck Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Head and Neck Cancer Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed